SEC reporting owner

Biller Jonathan SEC insider disclosures

Explore Biller Jonathan's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001744749
Issuers
3
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

CELGENE CORP /DE/0000816284CELGYesNo
AGIOS PHARMACEUTICALS, INC.0001439222AGIOYesNo
VERTEX PHARMACEUTICALS INC / MA0000875320VRTXYesNo
CELGENE CORP /DE/ ↗AGIOS PHARMACEUTICALS, INC. ↗VERTEX PHARMACEUTICALS INC / MA ↗

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

2026-02-272026-02-25VRTXS945Not reported
2026-02-202026-02-18VRTXS1,244Not reported
2026-02-202026-02-17VRTXS2,476Not reported
2026-02-202026-02-17VRTXA4,135Not reported
2026-02-192026-02-13VRTXS988Not reported
2026-02-132026-02-11VRTXS1,925Not reported
2026-01-272026-01-22VRTXA2,774Not reported
2026-01-272026-01-22VRTXA6,294Not reported
2025-12-062025-12-03VRTXS347Not reported
2025-10-042025-10-02VRTXS694Not reported
2025-02-202025-02-18VRTXS1,657Not reported
2025-02-152025-02-12VRTXA4,437Not reported
2025-02-132025-02-11VRTXS3,433Not reported
2025-02-072025-02-04VRTXA4,744Not reported

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.